Pacira BioSciences Inc (PCRX):企業の財務・戦略的SWOT分析

◆英語タイトル:Pacira BioSciences Inc (PCRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH23991FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Pacira BioSciences Inc (PCRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pacira BioSciences Inc (Pacira), formerly Pacira Pharmaceuticals Inc, provides non-opioid pain management and regenerative health solutions. The company develops drugs based on its proprietary DepoFoam drug delivery technology. Its lead product candidate, Exparel (bupivacaine liposome injectable suspension) is an amide-type local anesthetic administered at the time of surgery to control pain and eliminate the use of opioids for acute postsurgical pain. Its other products include iovera, an non-opioid treatment intended to block pain, pain relief and symptoms related with osteoarthritis of the knee; among others. Its products are essentially used by hospitals, doctors and ambulatory surgery centers. The company sells products through co-promotion agreements and supply agreements with other pharmaceutical companies. The company has operations in the US and the UK. Pacira is headquartered in Parsippany, New Jersey, the US.

Pacira BioSciences Inc Key Recent Developments

Mar 09,2021: Pacira BioSciences reports preliminary net product sales of $36.2 million for February 2021
Mar 03,2021: Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference
Feb 25,2021: Pacira BioSciences reports full-year and fourth quarter 2020 financial results
Feb 25,2021: Pacira Biosciences, to Host Earnings Call
Feb 10,2021: Pacira BioSciences reports preliminary net product sales of $36.0 million for January 2021

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Pacira BioSciences Inc – Key Facts
Pacira BioSciences Inc – Key Employees
Pacira BioSciences Inc – Key Employee Biographies
Pacira BioSciences Inc – Major Products and Services
Pacira BioSciences Inc – History
Pacira BioSciences Inc – Company Statement
Pacira BioSciences Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Pacira BioSciences Inc – Business Description
Product Category: Bupivacaine liposome injectable suspension
Performance
Product Category: Exparel
Overview
Performance
Product Category: iovera
Performance
R&D Overview
Pacira BioSciences Inc – Corporate Strategy
Pacira BioSciences Inc – SWOT Analysis
SWOT Analysis – Overview
Pacira BioSciences Inc – Strengths
Pacira BioSciences Inc – Weaknesses
Pacira BioSciences Inc – Opportunities
Pacira BioSciences Inc – Threats
Pacira BioSciences Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Pacira BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Pacira BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Pacira BioSciences Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 09, 2021: Pacira BioSciences reports preliminary net product sales of $36.2 million for February 2021
Mar 03, 2021: Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference
Feb 25, 2021: Pacira BioSciences reports full-year and fourth quarter 2020 financial results
Feb 25, 2021: Pacira Biosciences, to Host Earnings Call
Feb 10, 2021: Pacira BioSciences reports preliminary net product sales of $36.0 million for January 2021
Jan 07, 2021: Pacira reports record revenue for 2020 of $429.6 million
Dec 09, 2020: Pacira BioSciences reports preliminary net product sales of $38.9 million for November 2020
Nov 11, 2020: Pacira BioSciences reports preliminary net product sales of $41.7 million for October 2020
Oct 29, 2020: Pacira Biosciences reports third quarter 2020 financial results and business update
Oct 21, 2020: Pacira launches state-of-the-art training center dedicated to advancing best practice regional approaches to manage acute pain
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Pacira BioSciences Inc, Key Facts
Pacira BioSciences Inc, Key Employees
Pacira BioSciences Inc, Key Employee Biographies
Pacira BioSciences Inc, Major Products and Services
Pacira BioSciences Inc, History
Pacira BioSciences Inc, Other Locations
Pacira BioSciences Inc, Subsidiaries
Pacira BioSciences Inc, Key Competitors
Pacira BioSciences Inc, Ratios based on current share price
Pacira BioSciences Inc, Annual Ratios
Pacira BioSciences Inc, Annual Ratios (Cont...1)
Pacira BioSciences Inc, Annual Ratios (Cont...2)
Pacira BioSciences Inc, Interim Ratios
Pacira BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Pacira BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Pacira BioSciences Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Pacira BioSciences Inc (PCRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rothschild & Co SCA:企業の戦略・SWOT・財務分析
    Rothschild & Co SCA - Strategy, SWOT and Corporate Finance Report Summary Rothschild & Co SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Land O’Lakes, Inc.:企業の戦略・SWOT・財務情報
    Land O'Lakes, Inc. - Strategy, SWOT and Corporate Finance Report Summary Land O'Lakes, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Novita Healthcare Ltd (NHL):製薬・医療:M&Aディール及び事業提携情報
    Summary Novita Healthcare Ltd (Novita Healthcare), formerly Avexa Ltd is a medical technology company that focuses on the measurement and treatment of attention difficulties in early childhood. The company operates through its subsidiary The Tali technology, which is developing a tablet based softwa …
  • International Consolidated Airlines Group, S.A.:戦略・SWOT・企業財務分析
    International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Micell Technologies Inc:製品パイプライン分析
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company offers product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to optim …
  • Ascent Solar Technologies Inc (ASTI):電力:M&Aディール及び事業提携情報
    Summary Ascent Solar Technologies, Inc. (Ascent solar) designs, develops and manufactures thin-film photovoltaic modules. It pioneered the thin-film copper-indium-gallium-diselenide (CIGS) photovoltaic technology. The company employs monolithic integration process, which helps improve efficiency and …
  • Cadila Healthcare Ltd (CADILAHC):企業の財務・戦略的SWOT分析
    Cadila Healthcare Ltd (CADILAHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Biolase Inc (BIOL):医療機器:M&Aディール及び事業提携情報
    Summary Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser systems: WaterLase systems and Diod …
  • PUMA SE:企業の戦略・SWOT・財務情報
    PUMA SE - Strategy, SWOT and Corporate Finance Report Summary PUMA SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • BRT Apartments Corp.:企業の戦略・SWOT・財務情報
    BRT Apartments Corp. - Strategy, SWOT and Corporate Finance Report Summary BRT Apartments Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Pedernales Electric Cooperative, Inc.:企業の発電所・SWOT分析2018
    Pedernales Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Polenergia SA (PEP):企業の財務・戦略的SWOT分析
    Polenergia SA (PEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • RentPath LLC:企業の戦略的SWOT分析
    RentPath LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Emerson Electric Co (EMR):石油・ガス:M&Aディール及び事業提携情報
    Summary Emerson Electric Co. (Emerson) is a provider of infrastructure technologies and life cycle services for information and communication technology systems. The company offers hardware and software solutions for power, thermal and infrastructure management under the brands of Kop-Flex, jaure, a …
  • iNova Pharmaceuticals (Australia) Pty Ltd:企業の戦略的SWOT分析
    iNova Pharmaceuticals (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • HP Inc.:戦略・SWOT・企業財務分析
    HP Inc. - Strategy, SWOT and Corporate Finance Report Summary HP Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Shandong Weigao Group Medical Polymer Company Ltd (1066):企業の財務・戦略的SWOT分析
    Shandong Weigao Group Medical Polymer Company Ltd (1066) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company …
  • Lendlease Corporation Limited (LLC):企業の戦略的SWOT分析
    Lendlease Corporation Limited (LLC) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Grupo Posadas Sab De Cv:企業の戦略・SWOT・財務分析
    Grupo Posadas Sab De Cv - Strategy, SWOT and Corporate Finance Report Summary Grupo Posadas Sab De Cv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Hospira Inc:医療機器:M&Aディール及び事業提携情報
    Summary Hospira Inc (Hospira), a subsidiary of Pfizer Inc, is a medical device company that offers injectable drugs and infusion technologies. The company offers products such as generic acute-care and oncology injectables, biosimilars, infusion systems, IV sets, IV safety devices, biosimilars, diff …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆